Members Trust
LLY icon

Members Trust’s Eli Lilly LLY Stock Holding History

Members Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$903K Buy
753
+76
+11% +$77.7K 0.03% 63
2026
Q1 		$623K Sell
677
-5
-0.7% -$5.07K 0.02% 81
2025
Q4 		$733K Buy
682
+32
+5% +$30.6K 0.02% 67
2025
Q3 		$496K Sell
650
-32
-5% -$23.8K 0.02% 89
2025
Q2 		$532K Buy
682
+72
+12% +$55.9K 0.02% 76
2025
Q1 		$504K Buy
610
+183
+43% +$152K 0.02% 75
2024
Q4 		$330K Buy
427
+17
+4% +$14.1K 0.01% 90
2024
Q3 		$363K Buy
410
+92
+29% +$82.7K 0.01% 86
2024
Q2 		$288K Sell
318
-5
-2% -$4K 0.01% 99
2024
Q1 		$251K Buy
+323
New +$230K 0.01% 101
2022
Q1 		– Sell
-1,202
Closed -$332K – 122
2021
Q4 		$332K Buy
1,202
+6
+0.5% +$1.52K 0.01% 92
2021
Q3 		$276K Buy
1,196
+38
+3% +$9.38K 0.01% 100
2021
Q2 		$266K Sell
1,158
-284
-20% -$57K 0.01% 106
2021
Q1 		$269K Buy
+1,442
New +$282K 0.01% 91

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Members Trust's LLY Position: Q2 2026 in Review

Members Trust increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $77.7K and bringing the position to 753 shares worth $903K. The position accounts for 0.03% of the portfolio, ranked #63.

Members Trust first reported a position in LLY in Q1 2021 and has held it in 14 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Members Trust held 753 shares of Eli Lilly worth $903K as of Q2 2026.
  • Members Trust bought 76 Eli Lilly shares in Q2 2026, an estimated $77.7K.
  • Eli Lilly made up 0.03% of Members Trust's portfolio in Q2 2026, its #63 holding.
  • Members Trust first reported a position in Eli Lilly in Q1 2021 and has held it in 14 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Members Trust's 13F filing for Q2 2026, filed 31 Jul 2026.